top of page

Discover BioByte

From the Heart

BioByte is my very own passion project filled with unique and engaging content. Explore my site and all that I have to offer—perhaps my blog will spark excitement in your life, as well. So, sit back, relax and read on.

biotechnology.jpg
098da87c5931608c87bae60398438610_edited.jpg
WhatsApp Image 2023-03-15 at 1.07_edited.jpg
NEW PIC_edited.jpg
pic4.jpg
Post: Welcome

Dementia: Postnatal Onset Study

Updated: Feb 23, 2023


ree

Dementia is a symptom of Alzheimer's disease (AD), a neurological illness that gets worse over time. The hippocampus, one of the regions where neural stem cells reside and new neurons are created, is the site of the most noticeable neuronal loss in AD. Adult neurogenesis has been found to be reduced in many AD animal models. It is still unclear exactly when this impairment starts to show symptoms. When the neurogenic deficits in AD occur, from infancy through maturity, has been determined using the triple transgenic mouse model of AD (3xTg). Even in the neonatal stage, it has been shown that neurogenesis issues exist long before any neuropathology or behavioral abnormalities.


ree

Observations revealed that postnatal stages of 3xTg animals showed considerably lower numbers of neural stem/progenitor cells, decreased proliferation, and fewer newborn neurons, all of which are related to reduced hippocampal structural volumes. Bulk RNA-seq has been used on cells extracted directly from the hippocampus to examine the molecular fingerprints of brain stem/progenitor cells to check for any early changes. Genes from the Notch and Wnt pathways were among those whose expression patterns underwent observable changes around one month of age. These results show that the 3xTg AD model has very early neurogenesis deficiencies, providing new opportunities for early identification and treatment strategies to halt neurodegeneration in AD.


Source:




Comments


Post: Blog2_Post
bottom of page